Skip to main content
Clinical Trials/JPRN-UMIN000034778
JPRN-UMIN000034778
Completed
未知

Safety and efficacy of linagliptin for glycemic control in non-critically ill hospitalized patients with type 2 diabetes - Safety and efficacy of linagliptin for glycemic control in non-critically ill hospitalized patients

Ichinomiyanishi Hospital0 sites60 target enrollmentNovember 5, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Ichinomiyanishi Hospital
Enrollment
60
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 5, 2018
End Date
November 1, 2019
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patients admitted to or expected to require ICU admission; Patients with basal\-bolus insulin therapy, corticosteroid therapy,therapy of once weekly antidiabetic agents, clinically relevant gastrointestinal disease, impaired renal function (serum creatinine \>3\.0 mg/dL); and patients with a history of diabetic ketoacidosis and hyperglycemic crises pregnancy, or any mental condition rendering the subject unable to give informed consent.

Outcomes

Primary Outcomes

Not specified

Similar Trials